Sign in

ESCMID

@escmid.bsky.social
5.5K followers 176 following 1.2K posts

Championing medical progress in infection for a healthier tomorrow. ESCMID is committed to advancing the fields of clinical microbiology and infectious diseases.

PostsRepliesMedia
ESCMID @escmid.bsky.social · 12h
Today at 14:15 CEST, our BDBV webinar series continues with the 2nd instalment covering the vaccine development pipeline! Hear from experts at CEPI, the University of Oxford, the University of Antwerp and EMA. Register now and join us: ow.ly/4nTm50ZR1nH
012
ESCMID @escmid.bsky.social · 13h
🚨 New Epi Alert this week: The BDBV outbreak continues to expand in the DRC, with concerns about cross-border spread. West Nile virus & tick-borne encephalitis remain active, alongside updates on chikungunya, diphtheria, influenza, leptospirosis, yellow fever & measles. ow.ly/9HJm50Y3Qs0
011
ESCMID @escmid.bsky.social · 29/09/2026
⌛There's still time to register for this online course organised by the Emerging Infections Subcommittee! Explore why and how infectious threats emerge, how they are detected and contained, and how clinicians respond. Sign up today: ow.ly/TRYO50Ze89b
131
ESCMID @escmid.bsky.social · 29/09/2026
ESCMID Immediate Past President Robert L. Skov attended KMINE 2026 in Prague 17–19 September, where he addressed participants and delivered a keynote plenary lecture, strengthening collaboration between ESCMID and its affiliated societies in the Czech Republic.
000
Reposted by ESCMID
Clinical Microbiology and Infection @cmijournal.bsky.social · 28/09/2026
📣 In the October 2026 issue: The @escmid.bsky.social framework for reaching consensus in clinical guidelines www.clinicalmicrobiologyandinfection.org/article/S119... #IDSky #MicroSky
022
ESCMID @escmid.bsky.social · 28/09/2026
Emma Wall, ESGIB Chair, highlights the importance of #WorldRabiesDay. Learn more: 🔴 Later today join a special rabies webinar by ESGITM, ESGVM & EVASG: ow.ly/rJ0i50ZPy0N 💡 ESGIB’s webinar on rabies: ow.ly/WB9550ZPy0L 🎗️Global alliance: ow.ly/yWuY50ZPyso
021
ESCMID @escmid.bsky.social · 27/09/2026
🔎 Strengthen your skills in ID surveillance & IPC! Join the course for training on surveillance, diagnostics, antimicrobial stewardship, and more. This is part of the EUCIC certificate programme with a few spaces left! Learn more & register: ow.ly/M9s950ZzNGo
001
ESCMID @escmid.bsky.social · 26/09/2026
🦴🦠 This online course focuses on implant-associated infections, with special emphasis on prosthetic joint and fracture-related infections from infectious diseases, microbiology, and orthopaedic perspectives. 💡 Learn more and sign up today: ow.ly/U2NG50Z7ui6
121
ESCMID @escmid.bsky.social · 25/09/2026
Registration is open for the 3rd UEMS European Examination in Medical Microbiology, taking place on 28 Nov! This joint UEMS & ESCMID exam aligns with the UEMS Core Training Programme, European best practice guidelines & scientific literature. Register: uems-smm.eu/european-exam
111
ESCMID @escmid.bsky.social · 24/09/2026
#GAMRIC2026 is officially over and we want to thank all the partners, the programme committee and the attendees who made it such a massive success. We wish you a safe trip home and see you next year in Bangalore, India for #GAMRIC2027! CARB-X LifeArc Global Antibiotic R&D Partnership (GARDP)
121
ESCMID @escmid.bsky.social · 24/09/2026
That's a wrap on #GAMRIC2026! See today's highlights over on LinkedIn - lnkd.in/p/e9384VpM Thanks to all who attended and see you next year for #GAMRIC2027 in Bangalore, India. CARB-X LifeArc Global Antibiotic R&D Partnership (GARDP)
121
ESCMID @escmid.bsky.social · 24/09/2026
The final session for #GAMRIC2026 highlights the role of geopolitics in #AMR. These key talks bring up how global insecurity can influence treatment decisions, access, investment and more. CARB-X LifeArc Global Antibiotic R&D Partnership (GARDP)
110
ESCMID @escmid.bsky.social · 24/09/2026
The next instalment of our BDBV webinar series is next Wed, 30 Sept! The webinar will cover vaccine strategy, preparedness between outbreaks, the Tumaini Trial and evidence needed to support regulatory approval. Explore the programme & register today: ow.ly/GVs050ZMB30
122
ESCMID @escmid.bsky.social · 24/09/2026
Addressing #AMR is not just about finding new drugs to develop but also about ensuring access. This #GAMRIC2026 session focuses on access challenges with talks from Yann Ferrisse, Boumediene Soufi and Jaideep Gogtay. CARB-X LifeArc Global Antibiotic R&D Partnership (GARDP)
130
ESCMID @escmid.bsky.social · 24/09/2026
Discover the voices of the funders behind #AMR innovation in this session at #GAMRIC2026. We explored the issues and now we see how we can build funding to overcome these challenges from the perspectives of the funders. CARB-X LifeArc Global Antibiotic R&D Partnership (GARDP)
130
ESCMID @escmid.bsky.social · 24/09/2026
In the second session today at #GAMRIC2026 we explore issues in clinical development which highlights why partnerships, sharing and meetings like GAMRIC are so important. CARB-X LifeArc Global Antibiotic R&D Partnership (GARDP)
010
ESCMID @escmid.bsky.social · 24/09/2026
The final day of #GAMRIC2026 starts off with a session on phage therapy and highlights the importance of getting regulatory insights into the timing, approach and expectations of regulatory authorities in drug development. CARB-X LifeArc Global Antibiotic R&D Partnership (GARDP)
110
ESCMID @escmid.bsky.social · 23/09/2026
See the highlights from day 2 of #GAMRIC2026 in our LinkedIn post now live (lnkd.in/p/eicT6B5N) CARB-X LifeArc Global Antibiotic R&D Partnership (GARDP)
151
ESCMID @escmid.bsky.social · 23/09/2026
Lightning talks on day 2 of #GAMRIC2026 highlight innovation from around the globe with presenters from 5 continents exploring topics like health economics, directing R&D for impact and digital tools for #AMR surveillance in LMICs. CARB-X LifeArc Global Antibiotic R&D Partnership (GARDP)
120
ESCMID @escmid.bsky.social · 23/09/2026
The discussions continue at #GAMRIC2026 in this talk centred around policy and #AMR. Ana Burgos-Gutierrez gives a reality check about the EU Commission innovation-reward system and a new voucher available. CARB-X LifeArc Global Antibiotic R&D Partnership (GARDP)
130
ESCMID @escmid.bsky.social · 23/09/2026
Bringing together all aspects of the #AMR research lifecycle is a key benefit of #GAMRIC2026. In the current session, we hear from the different perspectives throughout the lifecycle including IPC, clinical, innovators and trial-design. CARB-X LifeArc Global Antibiotic R&D Partnership (GARDP)
142
ESCMID @escmid.bsky.social · 23/09/2026
🚨 New Epi Alert this week: BDBV continues to expand in the DRC, while West Nile virus spreads across Europe and measles transmission persists globally. Also: botulism in Denmark, mumps in the US, SFTS in Thailand & locally acquired malaria in Germany. ow.ly/9HJm50Y3Qs0
000
ESCMID @escmid.bsky.social · 23/09/2026
Day 2 of #GAMRIC2026 starts off with discussions on addressing the gaps and unmet needs in #AMR particularly how to accelerate impact in paediatric AMR and in LMICs. Talks by Marcela Ramirez, Nina Putri, Tanu Singhal CARB-X LifeArc Global Antibiotic R&D Partnership (GARDP)
131
ESCMID @escmid.bsky.social · 22/09/2026
Day 1 wrap-up of #GAMRIC2026 is now live on our LinkedIn (lnkd.in/p/e89DW9N3) CARB-X LifeArc Global Antibiotic R&D Partnership (GARDP)
132
ESCMID @escmid.bsky.social · 22/09/2026
#GAMRIC2026 participants are invited to connect and discuss the day's sessions and catch up with the latest developments in this first poster session. A great opportunity for all attendees to build their networks. CARB-X LifeArc Global Antibiotic R&D Partnership (GARDP)
130
ESCMID @escmid.bsky.social · 22/09/2026
Lightning talks at #GAMRIC2026 showcase some of the most innovative discoveries around #AMR which were submitted as abstracts. These presenters get the chance to present their work on the main stage before the poster session later today. CARB-X LifeArc Global Antibiotic R&D Partnership (GARDP)
120
ESCMID @escmid.bsky.social · 22/09/2026
Past-president Robert Skov opened up #GAMRIC2026 alongside Valeria Gigante and Radu Botgros highlighting the need to align #AMR priorities and what role #AI can play in drug development. CARB-X LifeArc Global Antibiotic R&D Partnership (GARDP)
150
ESCMID @escmid.bsky.social · 22/09/2026
The second Global AMR Innovators Conference (GAMRIC) has begun! Stay tuned for updates and join the conversation here using #GAMRIC2026. CARB-X LifeArc Global Antibiotic R&D Partnership (GARDP)
162
ESCMID @escmid.bsky.social · 21/09/2026
🚀Last call to register for the ESCMID leadership course! Secure your spot for this course before this Friday at 12:00 CEST (noon). Get ready to build practical leadership skills to navigate complexity, foster trust within teams and drive meaningful change. 💡Register now: ow.ly/lCfg50ZMAGp
111
ESCMID @escmid.bsky.social · 21/09/2026
#GAMRIC2026 starts tomorrow! We are excited to welcome you to Lisbon, Portugal and hope you enjoy the innovative programme and opportunities to connect. Follow along over the next days as we cover highlights from the conference. LifeArc CARB-X Global Antibiotic R&D Partnership (GARDP)
151
Reposted by ESCMID
CMI Communications @cmicomms.bsky.social · 20/09/2026
🎙️ Just published 'Does oseltamivir harm critically ill patients? The REMAP-CAP results' Hosted by Erin McCreary, PharmD & Josh Davis with invited guests Steve Webb & Steven Tong 🌟 Listen on #Communicable ow.ly/pJAO50ZOfK8 or on #Breakpoints ow.ly/p8Ti50ZOfK9 #IDSky #ViroSky #flu
ow.ly
Communicable E63: Does oseltamivir harm critically ill patients? The REMAP-CAP results | Communicable
1145
ESCMID @escmid.bsky.social · 20/09/2026
ESCMID-funded observerships offer an excellent opportunity for young scientist members and early-career LMIC members to gain experience and exchange knowledge at one of the over 100 ESCMID Collaborative Centres. Learn more and apply today! ow.ly/hwQg50ZN9SX
014
ESCMID @escmid.bsky.social · 19/09/2026
www.youtube.com/watch?v=5Djssln02fo #GAMRIC2026 starts in 3 days! www.gamric.org Jomana Musmar describes the need to forge a united path forward in the fight against AMR and how GAMRIC facilitates this. #AMR is not bound by borders and the threat is not looming, it is here today.
gamric.org
Gamric - Home
Global AMR Innovators’ Conference (GAMRIC), a new event connecting researchers, academics, and industry professionals from around the world to share insights about product development to address antimicrobial resistance (AMR). This science-focused meeting will feature plenaries, panels, and posters…
001
ESCMID @escmid.bsky.social · 18/09/2026
Learn how responsible antimicrobial use and effective infection control can help combat AMR. This onsite course is part of the ESCMID AMS Certificate Programme, with limited spots open to other participants. 💡 Register today: ow.ly/lwTi50ZGzue
112
ESCMID @escmid.bsky.social · 17/09/2026
🌟 Mark your calendars for the next instalment of our BDBV webinar series! Join us on 30 September at 14:15 CEST for a session covering vaccine strategy, preparedness between outbreaks, the Tumaini Trial & more! Explore the programme & register today: ow.ly/IcCN50ZMB2Z
021
Reposted by ESCMID
CMI Communications @cmicomms.bsky.social · 17/09/2026
📣 New #Communicable / #Breakpoints drops Mon 21 Sep! Erin McCreary, PharmD & Josh Davis are joined by Steve Webb & Steven Tong to discuss REMAP-CAP results suggesting that oseltamivir may harm critically ill patients, while also highlighting the importance and impact of RCTs. #IDSky #ViroSky #flu
0127
ESCMID @escmid.bsky.social · 17/09/2026
This #WorldPatientSafetyDay focuses on safe care for people living with noncommunicable diseases. Thomas Tängdén highlights the added risk infections can pose & the importance of prevention, diagnosis and treatment. Explore the topic on ESCMID Media: ⏯️ ow.ly/ryRe50ZNaJC
110
ESCMID @escmid.bsky.social · 16/09/2026
🔴 Starting in just a few minutes! Join the first webinar in our three-part series on Bundibugyo ebolavirus vaccines. Register now and join the livestream: ow.ly/fNBo50ZAwJH
000
ESCMID @escmid.bsky.social · 16/09/2026
🚨 New Epi Alert this week: the DRC’s Bundibugyo virus outbreak expands to a seventh province. Also this week: measles in Bangladesh, leptospirosis in the Philippines, hepatitis A in Costa Rica, diphtheria in Senegal & West Nile virus in the Netherlands. ow.ly/9HJm50Y3Qs0
131
ESCMID @escmid.bsky.social · 15/09/2026
💡 Take your clinical trial from concept to completion. Learn how to design, conduct and report a clinical trial through expert-led sessions and workshops covering every stage of the clinical trial journey. Register today: ow.ly/lStL50Zrgqa #IDSky CMI Communications CLARITY_Initiative
011
ESCMID @escmid.bsky.social · 14/09/2026
Eva Krockow highlights the need to involve diverse perspectives to help promote #AMR action such as social scientists bringing forward expertise in communication. www.youtube.com/watch?v=TbomvTP8Xyg Just over a week until #GAMRIC2026: www.gamric.org/registration-travel-…
001
Reposted by ESCMID
Clinical Microbiology and Infection @cmijournal.bsky.social · 14/09/2026
In honor of #PeerReviewWeek we would like to thank our peer reviewers for their important and insightful contributions to CMI. We deeply value the time, effort and expertise that goes into writing each peer-review.
044
ESCMID @escmid.bsky.social · 13/09/2026
🚀Good news! The registration deadline for our ESCMID leadership course has been extended to 25 Sep! Secure your spot and build practical leadership skills to navigate complexity, foster trust within teams and drive meaningful change. 💡Register now: ow.ly/j0c650ZMAGj #IDSky #clinmicro
001
ESCMID @escmid.bsky.social · 13/09/2026
🩺 Today marks #WorldSepsisDay. Brigitte Lamy, Chair of ESGBIES, highlights the study group’s commitment to advancing sepsis diagnosis and treatment through education, research & collaboration. 💡 Discover ESGBIES activities: ow.ly/PUBx50ZBrIC
001
ESCMID @escmid.bsky.social · 12/09/2026
Build your knowledge of classical and emerging hepatitis viruses, from hepatitis A–E to viral haemorrhagic fevers including yellow fever, dengue & Crimean-Congo haemorrhagic fever. A must for those interested in viral liver diseases. Register today: ow.ly/rzas50ZGvGF
000
ESCMID @escmid.bsky.social · 11/09/2026
🧬 Strengthen your plasmid bioinformatics skills at this hands-on onsite course in Copenhagen. Learn how to analyse plasmids from bacterial whole-genome sequencing data to support AMR surveillance and outbreak investigations. 💡 Register today: ow.ly/lslb50ZvKJE
132
ESCMID @escmid.bsky.social · 10/09/2026
⏳ One week left to apply for the ESCMID Mentorship Programme! Connect with an experienced ESCMID mentor, define your goals & take the next step in your professional development. 🚀 👉 Apply by 17 Sept: ow.ly/pYZH50ZGzOH
000
ESCMID @escmid.bsky.social · 10/09/2026
⏳ Last call for ESCMID’s new leadership course! Build practical skills to navigate complexity, foster trust within teams & drive meaningful change. 💡 Add-on: Leading as a woman in healthcare 📅 Register by 13 Sept: ow.ly/ia5L50ZtO6L
010
ESCMID @escmid.bsky.social · 09/09/2026
💉 Next Wednesday marks the first webinar in our 3-part series on Bundibugyo ebolavirus (BDBV) vaccines! Learn about cross-protection following Zaire ebolavirus vaccination and what this could mean for BDBV. 👉 Explore the programme & register: ow.ly/fNBo50ZAwJH
010
ESCMID @escmid.bsky.social · 09/09/2026
🚨 New Epi Alert this week: This week’s Epi Alert highlights continued vector-borne and viral haemorrhagic fever activity across Europe and Africa including updates on West Nile virus, dengue, malaria and the continuing BDBV outbreak. ow.ly/9HJm50Y3Qs0
011